Theme: Fight the fight, Find the cure

STD Asia Pacific 2018

Renowned Speakers

STD Asia Pacific 2018

Conference Series LLC Ltd invites you to attend the 8th Asia Pacific STD and Infectious Diseases Congress held during November 12-13, 2018 at Tokyo, Japan with the theme “Fight the fight, Find the cure”.  STD Asia Pacific 2018 has been outlined in an interdisciplinary way with foster discussion by maximizing interactions, collaborations and networking opportunities for Invited speakers, Medical professionals, Business experts, Researchers and scientists mainly emphasis on large-scale research approaches and technologies in the session tracks to provides with a unique opportunity to get together at our II-Days scientific program.

STD Asia Pacific 2018 is an expertise meeting that spotlights and examine the latest scientific developments in HIV and Infectious Diseases-related research with a focus on moving science into practice and policy. We trust that you will exploit this opportunity and join with us at this remarkable occasion. It is an extraordinary approach to construct associations with partners and share knowledge and experience with their colleagues around the globe. The key point of STD Asia Pacific 2018 is to share logical revelation and clinical care on HIV, AIDS, STD and infectious diseases. In addition, you'll have the chance to associate with companions and celebrate your profession at this II-Days event.

Why to attend?

The present research on Emerging technologies and Strategies, improvements, most current updates in HIV, AIDS, STD and infectious diseases are hallmarks of this Conference.

Lead introductions, disseminate data, foster networking with present and potential specialists, make a splash with latest improvements, and participation acknowledgment at this 2-day occasion. STD Asia Pacific 2018 makes you move, learn and embrace better approaches to enhance Medical professional career prospects.

Target Audience:

  • Medical Professionals & Physicians
  • Nurse-practitioners & Pharmacists
  • Psychologists &  Abuse, Behavioral specialists
  • Infectious diseases doctors & Public Health care Researchers
  • Social workers, AIDS service organization (ASO) staff
  • National government agencies and consultants  
  • Epidemiologists, Bacteriologist, Virologists, Microbiologists, Oncologists
  • Geneticist, Gynecologist, Clinical experts
  • Business experts / Manufactures & suppliers/ Aspiring Entrepreneurs, Sales Manager.
  • Media partners and Collaborators
  • International Delegates and global observers

STD Asia Pacific 2018 is the reputed conference which aims to provide best platform to explore the emerging strategies for the prevention and treatment of sexually transmitted diseases.

Join us for a symphony of outstanding science, and enjoy the spectacular and unique beauty of Tokyo, Japan.

For long lasting scientific relation follow us    

On behalf of Conference series LLC LTD., we take immense pleasure in inviting all the participants over the world to attend the “9th Asia Pacific STD and Infectious Diseases Congress” which will be held during October 21-22, 2019 at Tokyo Japan with the theme “Advancements, Novel approaches for prevention & control of STD and Infectious Diseases”.

Why to attend?

The present research on Emerging technologies and Strategies, Prevention and advanced Diagnosis, improvements, the most current updates in HIV, AIDS, STD and infectious diseases are hallmarks of this Conference. Lead introductions, disseminate data, foster networking with present and potential specialists, make a splash with latest improvements, and participation acknowledgment at this II day occasion. STD Asia Pacific Congress 2019 makes you move, learn and embrace better approaches to enhance Medical professional career prospects.

Target Audience:

  • Medical Professionals & Physicians
  • Nurse-practitioners & Pharmacists
  • Psychologists &  Abuse, Behavioral specialists
  • Infectious diseases doctors & Public Health care Researchers
  • Social workers, AIDS service organization (ASO) staff
  • National government agencies and consultants 
  • Epidemiologists, Bacteriologist, Retro-virologists, Microbiologists, Oncologists
  • Geneticist, Gynaecologists, Clinical experts
  • Business experts / Manufactures & suppliers/ Aspiring Entrepreneurs, Sales Manager.
  • Media partners and Collaborators
  • International Delegates and global observers
  • Students and Young Researchers.

STD Congress 2019 Conference Unique Opportunities

For Researchers and Faculty Members:

Speaker Presentations

Poster Display

Symposium hosting (4-5-member team)        

Workshop organizing 

For Universities, Associations & Societies:

Association Partnering

Collaboration proposals         

Academic Partnering  

Group Participation

For Students and Research Scholars:

Poster Competition (Winner will get Best Poster Award)       

Young Researcher Forum (YRF Award to the best presenter)

 Student Attendee       

Group Registrations   

For Business Delegates:

Speaker Presentations

Symposium hosting   

Book Launch event   

Networking opportunities      

Audience participation

For Business Entities :

Exhibitor and Vendor Booths

Sponsorship opportunities

Product launch

Workshop organizing

Scientific Partnering

Marketing and Networking with clients

STD Asia Pacific Congress 2019  is the reputed conference which aims to provide best platform to explore the emerging strategies for the prevention and treatment of sexually transmitted diseases.

Join us for a symphony of outstanding science, and enjoy the spectacular and unique beauty of Tokyo, Japan.

For long lasting scientific relation follow us    

Thanks and Regards

STD Asia Pacific Congress 2019

Email: |

Track 1. Sexually Transmitted Diseases

The term ‘Sexually Transmitted Diseases’ (curtailed STDs) alludes to a cluster of sicknesses that can be transmitted beginning with one individual then onto the following through the sharing of body liquids, including discharge, vaginal liquids, blood, and distinctive fluids. They have a wide range of causes (counting microscopic organisms and infections), they deliver an assortment of manifestations (or nonattendance of side effects), and they have altogether different impacts on the body when left untreated which is specified as STD symptoms.

Sexually transmitted ailments are transmitted when body fluids from a polluted individual come into indicate contact with another person. As their name infers, the most well-known course through which this body fluid sharing happens is sexual activity.

STD Symptoms | STD Testing | STD Diagnostic kit

Track 2. Viral STD

Virus a small infectious organism littler that than a growth and bacterium which invades a host cell to repeat. Viral disease fuses a progression of ventures with connection to the host cell to be the principal following with exchange of RNA or DNA for the replication procedure of the infection.

Viral Infection Testing | Bacteriology

Track 3. Bacterial STD Infection

Venereal diseases additionally named as bacterial contamination normally spread by sex. These STIs when obtained previously or during birth results in birth defects and might also cause the inability to be pregnant.

Immune system | Infants

Track 4. Protozoan Infection and Prevention

Pathogenic living beings are the operators of infectious diseases. Straightforwardly or in a roundabout way starting with one individual then onto the next these irresistible maladies can offer ascent to different wrecking medical problems.

There are a couple of ways that a parasite can sully a host. Various parasites experience chaotic water. Water bornepathogens are ordinary in places where the water is untreated and dirtied by sewage. It is horrifying anyway the best course for such a parasite to spoil another host is to leave the old host in excrement and a while later get again into another host when water sullied by sewage is eaten up.

Influenza | Fatal | Diarrhea

Track 5. Infertility & Birth Defects

The connection between barrenness, birth surrenders with disease is for quite some time known. Asymptomatic diseases caused by specific contaminations are additionally crushing as the nonattendance or absence of manifestations keeps the patients from looking for auspicious therapeutic mediation which subsequently prompts perpetual harm of the pelvic organs.

Chlamydia, among the most well-known sexually transmitted infections, influences an expected 100,000 pregnant ladies every year, as indicated by the Centers for Disease Control and Prevention.

Premature birth of the baby which happens before 37 weeks of the pregnancy; Birth deserts which is the strange shapes and capacity of the infant.

Immunosuppression | Immunological diseases | Heart disease

Track 6. Emerging and Re-emerging Infectious Diseases

Developing Infectious Diseases are those whose rate or geographic range is quickly expanding or debilitates to increment sooner rather than later. The ascent of new irresistible sicknesses or the re-development of the old irresistible ailments is supported by numerous components like advancement of the pathogens, human behavior and practice.

The developing sicknesses can be built up by its presentation into a populace and its capacity to spread starting with one individual then onto the next. Numerous rising and re-rising irresistible infections have been found like Hemorrhagic fever, Encephalitis, Zika virus & West nile virus etc.

Harpies disease | Autoimmune disease

Track 7. Immunology of Infectious Diseases

Despite whether a compelling ailment administrator is an "old partner" or another, creating hazard, the sheltered system's battle against it is normally the principal line of resistance. The safe reaction is the best way to destroy the irresistible illness when the drug is inaccessible.

Autoimmune disease

Track 8. Immune response

The invulnerable reaction to a disease depends if the contamination is out of the blue or the contamination has happened previously. When At the point when the pathogen has just assaulted once and has produced the memory cells in the host the reaction to the contamination will be exceptional on the following presentation. The invulnerable reaction to the remote body in the host is because of arrangement of other reaction from the resistant cells.

Natural immune booster

Track 9. Gene Editing approaches towards HIV

Viable new quality changing systems ensure significant open entryways for novel healing contrasting options to imperative ailments, including growth, hereditary scatters, genetic disorders and viral infections. Procedures like zinc finger nuclease, interpretation activator-like effector nucleases and clustered regulatory interspaced short palindromic rehash.

Human Molecular Genetics | Hetero Genetic

Track 10. Molecular method of diagnosis of STDs

From late years, the headway and utilization of sub-nuclear diagnostic frameworks had made a change in the finding and checking of irresistible sicknesses. Atomic diagnostics are used to recognize compelling diseases like chlamydia, flu infection and tuberculosis. Innate recognizing verification can be made for example circle interceded isothermal upgrade test dissect the intestinal affliction parasite in the creating nations. Regardless of these advances in genome examination, in 2013 infections are still more consistently recognized by different means like proteome, bacteriophage, or chromatographic profile. Sub-nuclear diagnostics are used to appreciate the specific strain of the pathogen—for example by perceiving which quiet opposition characteristics it has—and consequently which treatments to maintain a strategic distance.

Sexually Transmitted Infection | Diagnostic Diseases | Genetic Infections

Track 11. HIV/STD Testing

The Centers for Disease Control and Prevention (CDC) propose HIV testing as a typical bit of restorative watch over pre-grown-up or grown-up between the ages of 15 and 65 in any event once. Sexually transmitted maladies may be distinguished in the midst of a physical exam; through Pap smears; and in preliminary of pee, blood, and genital and butt- driven outflows. For STDs– like herpes, hepatitis, HIV and syphilis, a little blood test is used for the STD testing while chlamydia and gonorrhea test is done with a pee test.

HIV test kit | Neurological Disorders | Syphilis Test

Track 12. Drug Discovery and techniques

Prescription disclosure and advancement is a costly technique because of the high use in the R&D and human clinical preliminaries testing. The typical total cost per sedate change varies from US$ 897 million to US$ 1.9 billion. The run of the mill improvement time is 10-15 years. For the research of the new drug it involves the identification of the target site for the drug interaction for the blocking process.

Track 13. Prevention &Treatment

Irresistible maladies balancing activity and control is helpful to keep the transmission of compelling contaminations. STI control attempts have continuously been described in association with HIV program needs cap are financed, executed and assessed freely of other STI control endeavors. STI control is a general wellbeing result, estimated as diminished rate and commonness, accomplished by executing systems made out of different synergistic interventions.

Track 14. Prevention of mother to child transmission

2.3 million HIV contaminations were found comprehensively. Extensive piece of the populace found with HIV disease found was in their regenerative stage and the people determined to have HIV were probably going to need kids. Perinatal transmission of HIV, additionally called as Vertical Transmission, happens when HIV is contaminated from HIV-positive ladies to her infant amid pregnancy, work and conveyance or breastfeeding. The percentage of transmission ranges from 15 to 45% during pregnancy, labor and delivery. The rate of transmission increases to additional 35 to 45% when there is breast feeding by the mother to child. The transmission rate depends on the type of STD and the mode of transfer. Level of transmission ranges from 15 to 45% amid pregnancy, work and conveyance. The rate of transmission increments to extra 35 to 45% when there is bosom encouraging by the mother to kid. The transmission rate relies upon the sort of STD and the method of exchange.

HPV | Dehydration

Track 15. Global Market and Ebola Outbreak Prevention

In this day and age the sexually transmitted sicknesses are a standout amongst the most basic wellbeing challenges. Almost 500 new million new instances of STD are enlisted every year and the people contaminated are in the age furthest reaches of 15 to 44 years. The STDs worldwide testing market was esteemed at $107,024 million of every 2015, and assessed to reach $190,010 million by 2022, enlisting a CAGR of 8.5% over the gauge time frame. Microfluidics is likely developed speediest, developing at a CAGR of 34.2% inferable from the usability, mechanical headways, and fast outcomes in diagnostics.

Ebola hemorrhagic caused by virus belonging to the family Filoviridae  which is also called as Filo virus. This virus is also known as Zoonotic Virus as it is transmitted from animals to humans. This disease was first appeared in 1976 in 2 simultaneous outbreaks but the largest outbreak was discovered in West Africa which was also the most complex outbreak from the time it was discovered. Fruit bats of the Pteropodidae family are natural Ebola virus hosts the transmission is done from the by the close contact with the blood.

Therapy | Viral Epidemics

Track 16. Zoonotic and Bioinformatics for Infectious Diseases

The exchange of the pathogens causing the sicknesses can be framing one individual to another. In any case, when the infection is exchanged from creatures to people the ailment is been named as zoonotic sicknesses. The method of exchange of the irresistible operators can be from various perspectives like direct contact, indirect contact, vector-bornefood borne.

That bioinformatics pathogen profiling can foresee the patient result and furthermore discover the markers for the early analysis and keep the staggering results. Utilizing bioinformatics as the device a pathogen profile can be considered as a solitary multivariate perception or an arrangement of perceptions, included classes of particular traits, which are intended for an examination with a knowledgebase. The nearness of a few dreary arrangements in the genome of the pathogen can be utilized for the comparison.

Causes of HIV | Chromosomes

Track 17. Mechanism of Resistance

Enzymatic annihilation, enzymatic change, adjusted target and diminished take-up are the different courses by which the pathogenic living being indicates protection the antimicrobial substance. The obstruction is realized by the adjustment in the objective site or the change or the inactivation of the anti-microbial, alteration of metabolic pathway to lessen the anti-microbial impact to the living being, diminishing the deluge by diminishing the permeability.

Track 18. Database for Infectious Diseases

Restorative learning mapped into social database shapes the spine to file illnesses data. Irresistible illnesses social database shapes the choice help device for wellbeing experts. To recognize or analyze irresistible illnesses, data mapped into social database offers the connection with the information of the known social. 275 compelling ailments are portrayed by arrangement, contamination form, and sharpness. Classes fuse Arthropod-Borne, Biological Weapons, Childhood Infections, Community-Acquired, Foodborne, Gastroenteritis, Localized Infections, Sapronoses, Sexually-Transmitted, and Zoonosis'.Illness writes are Bacteria, Fungus, Helminthes, Mixed, Other, Protozoa, Rickettsia, Spirochete, Toxin, and Virus.

Track 19. Infection and Cancer

Tumor and overwhelming diseases are totally unquestionable classes of sicknesses. Regardless, occasionally they may give near signs and signs. They are anyway treated with different modalities of treatment. Typically, irresistible maladies don't pass on the destroy perspective of hurtful tumors, in spite of the fact that a contamination might be lethal or create toward the finish of treatment of a malignancy.

Humoral Immunity | Parasitology


Related Conferences:

8th  Microbiology Conferences February 22-23, 2018 Paris, France; 16th Microbiology Conferences, May 21-23, 2018, Vienna, Austria; 9th  Emerging Infectious Diseases Conferences, 31st August-1st September 2018 Zurich, Switzerland; 4th  Rare Diseases Conferences, June 11-12, 2018 Dublin, Ireland; 6th  Bacteriology  Conferences May 25-26, 2018 New York, USA; 6th STDs, STIs & HIV/AIDS Conferences, October 29-30 , 2018 Madrid, Spain, 4th  Influenza Conferences July 2-3, 2018 Vienna, Austria 10th  Virology Conferences July 2-4, 2018 Vienna, Austria,. 11th Medical Microbiology Conferences July 19-21, 2018 Rome, Italy. 2nd  STDs, STIs & HIV/AIDS Conferences, Montreal, Canada, May 18-19, 2018; 16th Influenza Conferences, Orlando, USA, March 28-29, 2018; 8th Inflammatory Diseases Conferences, Vienna, Austria, May 21-22, 2018; Bacteriology Conferences, Paris, France, June 18-19, 2018; 8th  Infectious Diseases Conferences, London, UK, June 07-08, 2018; 10th Microbiology Conferences, June 14-16, 2018, London, UK; 7thMicrobiology Research Conferences, August 13-14, 2018, Madrid, Spain; Microbial Biotechnology Conferences, September 17-18, 2018 Lisbon, Portugal; 2nd Medical and Clinical Microbiology Conferences, July 16-17, 2018 Melbourne, Australia; Microbial physiology Conferences July 16-18, 2018 London, UK.

Related Societies and Associations:

Europe:  International AIDS Society (IAS) , Joint United Nations Programme on HIV and AIDS (UNAIDS) Spanish Society of Pediatric Infectious Diseases, Spain; Spanish Society of Pediatric Clinical immunology and Allergy, Spain; Spanish Association of Pediatric Primary Care, Spain, British Society for Immunology, U.K; European Society for Immune deficiencies, Switzerland.

USA: Association of Medical Microbiology, UK; Canadian Association for Clinical Microbiology and Infectious Diseases, Canada; National Institute of Allergy and Infectious Diseases, USA; Canadian Public Health Association, Canada; Tropical Pathology & Infectious Diseases Associations, Peru; International Society for Infectious Diseases, USA.

Asia Pacific: Philippine Hospital Infection Control Society, Philippine; New South Wales Infection Control Association, Australia; Victorian Infection Control Association, Australia; Victorian Infection Control Professionals Association, Australia; Infection Control Practitioners Association of Queensland, Australia.

STD Asia Pacific 2018 conference is the global leading event which was held between continents and is organized in collaboration with regional STD and Infectious Diseases societies with the innovative theme “Fight the fight, Find the cure”.

Scope and Importance of STD & Infectious disease Research

According to recent statistical it was reported the abrupt increase in the death case studies was due to  spread of infectious diseases and this infection and spreading could be prevented with the help of Health care professionals. Contamination aversion and control measures expect to guarantee the assurance of the individuals who may be powerless against procuring a disease. STDs are an important global health priority because of their devastating impact on women and infants and their inter-relationships with HIV/AIDS. STDs and HIV are linked by biological interactions in which infections can occur in the same populations. Infection with certain STDs can increase the risk of getting and transmitting HIV as well as alter the way the disease progresses. In addition, STDs can cause long-term health problems, particularly in women and infants. Some of the health complications that arise from STDs include pelvic inflammatory disease, infertility, tubal or ectopic pregnancy, cervical cancer, and perinatal or congenital infections in infants born to infected mothers. The global concerns of sexually transmitted infections (STIs) remains at the higher edge. 

Why Japan?

HIV/AIDS has been a global phenomenon due to the delay in the research, development and health care sector.  The reported number of cases for the HIV in females of Japan is 459 and 169 for AIDS science the beginning of surveillance in 1984 through the end of 2003 where most of them are affected by heterosexual contact. The rate of the number of people diagnosed with HIV/AIDS is increasing with 30 people annually.

Examining data by age group, there is a drastic increase among young people. In the age group 15-24, female HIV/AIDS cases exceed males (70.6% of ages 15-19 and 55.1% of ages 20-24 in HIV reported cases are female. These age groups are distinctive from other age groups where the majority is male). HIV positive pregnant women make up less than 1% of the total number in the report, but some data suggests that a higher rate is expected than that of non-pregnant women in some regions. In these situations, prevention measures for young people are considered to be a top priority.

Increase in the Global STD diagnostics market, by types, 2012-2022, (USD Billion)

In STD Asia Pacific 2018 conference has been fostering the need to control the impact of permanent Sexually transmitted infections within the public health environment. The STD diagnostics industry is estimated to experience growth majorly due to rising prevalence of various infections such as chlamydia, syphilis, gonorrhea, herpes simplex virus, human papilloma virus, human immunodeficiency virus, chancroid, and other infections including trichomonas vaginalis and vaginitis.

Bacterial STIs include gonorrhea, chlamydia, and syphilis while viral STIs include genital herpes, HIV, genital warts (HPV), and hepatitis. The microorganisms causing STIs reside in blood, semen, and vaginal fluid. STDs caused by chlamydia dominated the overall market in terms of revenue and was valued at around USD 6.00 billion in 2014. However, diagnosis of sexually transmitted diseases caused by syphilis is rising and is estimated to account for over 20% of the market by 2022, growing at a healthy CAGR over the forecast period due to increasing prevalence of syphilis infections worldwide.

Statistics of Marketers, Researchers working on STD and infectious diseases

Case report for curable STD :

In 2012, there were an estimated 357 million new infections (roughly 1 million per day) of the four curable STIs – chlamydia, gonorrhoea, syphilis and trichomoniasis. Prevention and control of STIs are an integral component of the comprehensive sexual and reproductive health services needed to attain the Sustainable Development Goals (SDGs) to reduce child and neonatal mortality (3.2), to end the epidemics of AIDS and other communicable diseases (3.3), to reduce non communicable diseases, and to improve mental health (3.4), sexual and reproductive health (3.7) and to achieve universal health coverage (3.8). Surveillance is a key element of the World Health Organization (WHO) STI prevention and control strategy and is an important component of second-generation surveillance systems for human immunodeficiency virus (HIV).

Global estimates of new cases of curable STIs in 2012-2017

Considering the abortion rates and the STD count it is been observed that women in their teens to early 20s are considered to be the high risk group. Some studies show that sexual contact with irregular partners are very common in young people, and the ratio of condoms use is low with regular partners and even lower with irregular partners.

Vulnerable group in women is not only young people. Women over 55 were the least likely to use condoms comparing with other age groups. Menopause is considered to be one of the reasons for not using condoms, as contraception is no longer an issue for them.

The abortion rate in 2002 is highest among women in their early 20s (20.3%), but it has also been found that women in their late 20s and 30s have rates as high as 12 to 15%. In these groups, the rate of condom use is decreased. Regarding women and HIV/AIDS, mother-to-child transmission has always been considered as a major issue in the medical or public arena while other topics have been rarely discussed. Nowadays, transmission from HIV-infected women to their infants can be reduced to 2% by provision of antiretroviral drugs, safe delivery practices and avoiding breastfeeding.

Fund Allotment to STD and Infectious diseases Research

Domestic funding is STD and infectious disease spending, by country governments in their national budgets. The Global Fund , The World Bank , The United Nations are the Key Multilateral funding Institutions Involved in STD, HIV/AIDS  and other infectious diseases. Historically, the HIV response has been largely funded by international donors and governments, but low- and middle-income countries are now beginning to lead on efforts to finance their STD response. The President’s Emergency Plan for AIDS Relief (PEPFAR), USA-WHO accounted for the majority of bilateral and multilateral funding from donor governments in 2017 (US$4.9 billion), followed by the United Kingdom (UK) (US$645.6 million), France (US$242.4 million), the Netherlands (US$214.2 million) and Germany (US$182 million), these five countries have accounted for roughly 80% of all HIV funding from donor governments.

Private funders The charitable  and  corporate philanthropic organisations provided US$680 million for global STD,HIV and AIDS programmes in 2017.The  largest funders — The Bill and Melinda Gates Foundation and Gilead Sciences ViiV Healthcare, Aidsfonds, Kaiser Family Foundation and Elton John AIDS Foundation.

African Union (AU) endorses major new initiatives to end up AIDS by 2030 .The Joint United Nations Programme on STD and Infectious diseases  (UNAIDS)with Abuja Declaration leads and inspires the world to achieve its shared vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths. UNAIDS unites the efforts of 11 UN organizations—UNHCR, UNICEF, WFP, UNDP, UNITAID, UNFPA, UNODC, UN Women, ILO, UNESCO, WHO and the World Bank which works closely with global and national partners towards ending the STD, HIV and AIDS epidemic by 2030 as part of the Sustainable Development.

Japan International Cooperation Agency (JICA); Ministry of Foreign Affairs (MOFA); Ministry of Health; Ministry of Finance; Japan Bank for International Cooperation (JBIC); Japan International Corporation of Welfare Services (JICWELS)

Japanese Societies associated with STD and Infectious Diseases

The Japan Society of Medical History

The Japanese Society of Pathology

Japanese Association of Anatomists

The Japanese Cancer Association

Physiological Society of Japan

The Japanese Society of Hematology

The Japanese Biochemical Society

Japanese Society for Bacteriology

The Japanese Pharmacological Society

The Japanese Society of Parasitology

The Infectious Diseases Society of America

Japanese Society of Legal Medicine

Japanese Society for Hygiene

The Japanese Society of Health and Human Ecology

Japan Society of Nutrition and Food Science

The Japanese Society of Balneology, Climatology and Physical Medicine

The Japan Endocrine Society

The Japanese Society of Internal Medicine

Japan Pediatric Society

The Japanese Association for Infectious Disease

The Japanese Dermatological Association

The Japanese Society for Virology

American Society for Microbiology

Australian Society for Microbiology

Australian Society of Antimicrobials

Philippine Society for Microbiology

French Society for Microbiology

Society  of Tropical Medicine and Infectious Diseases

Society for Applied Microbiology

American Society for Virology

The Japanese Society of Internal Medicine    

Japanese Society for infection Prevention and control

The Japanese Association for Infectious Diseases


Major Manufacturing Companies associated with STA and Infectious Diseases in Japan

Major companies operating in the STD diagnostics arena include Roche Holdings AG, Abbott Laboratories, Becton Dickinson and Company, Hologic Inc., Danaher Corporation, Affymetrix, bioMerieux, Cepheid Inc., Alere Inc., DiaSorin, and Orasure. These companies focus on the partnership and product/technology licensing opportunities in the sexually transmitted diseases diagnostics industry. Below are the Products Manufacturing Companies for Infectious Diseases and STD in Japan

  • Shigematsu Co., Ltd
  • Shionogi
  • ViroQuest
  • ViiV Healthcare Ltd.
  • Otsuka Pharmaceutical
  • Mogi Pharmaceutical Co., Ltd.
  • Alfresa Holdings Corporation
  • Mogi Pharmaceutical Co., Ltd.
  • Alfresa Pharma Corporation
  • Wakunaga Pharmaceutical
  • Oncolys BioPharma
  • BioReliance (SAFC)
  • IDAC Theranostics
  • Mochida Pharmaceutical
  • Nippon Kayaku

Japan Major Universities and research associated with STD and Infectious Diseases in Japan

The University of Tokyo, Yokohama City University , Keio University, Waseda University, University of Tsukuba, Chiba University Hospital, The University of Tokyo Hospital., Infectious Disease Surveillance Center,  Tohoku University, Nagoya Medical Center, Kitasato University School of Medicine, Hiroshima University, Kanazawa University, Kyoto University Infectious disease and control, NIHON University, School of Medicine, General Internal Medicine and Infectious Diseases, Kameda Medical Center, Kobe University Hospital, Shizuoka Cancer Center, The Canon Institute of Global sciences , The Japanese Society of Internal Medicine, The Japanese Association for Infectious Diseases,The Japanese Society of Laboratory Medicine, The Japanese Association for Infectious Diseases.

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date November 12-13, 2018
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1 Day 2
Poster Opportunity Closed Click Here to View